A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Sunitinib
Related studies linked through entity extraction aliases.
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
- Status
- AVAILABLE
- Phase
- N/A
Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
- Status
- RECRUITING
- Phase
- PHASE2
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
- Status
- RECRUITING
- Phase
- PHASE3
Losartan + Sunitinib in Treatment of Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Pan Tumor Rollover Study
- Status
- RECRUITING
- Phase
- PHASE2
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Savolitinib vs. Sunitinib in MET-driven PRCC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2